PRISM MarketView – Biotech Breakfast
April 15, 2024
Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 – PRISM MarketView
Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 – PRISM MarketView
SAN FRANCISCO, CA, April 12, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic
IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 – Oncocyte Corporation (Nasdaq: OCX), a
– Bio-Rad expects to make equity investment in support of deal – Agreement provides for global exclusivity in transplant monitoring commercialization – Bio-Rad granted subsequent
Las Vegas, NV, April 11, 2024 – Auto Parts 4 Less Group, Inc. (OTC: FLES) (“AutoParts4Less,” “the Company”), a technology-driven e-commerce leader in the automotive
First-ever telesurgery using SSi Mantra performed on an animal in India FORT LAUDERDALE, FL, April 10, 2024 – SS Innovations International, Inc. (the “Company” or
LAS VEGAS, NEVADA, April 09, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in developing
Conference Call and Webcast on Friday, April 12, 2024, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 09, 2024 – Oncocyte Corporation
12-Month Net Sales Reached ~$19.7 million, Gain of ~31% for FY2024 ended Feb 29, 2024 Q4 Net Sales Grew ~30% YOY; Backlog Grew ~7% YOY
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850